Acalabrutinib monotherapy for treatment of chronic lymphocytic leukaemia (ACE-CL-001): analysis of the Richter transformation cohort of an open-label, single-arm, phase 1–2 study

Toby A. Eyre, Peter Hillmen, Jennifer R. Brown et al.|The Lancet Haematology|2021

Cited by 60